CompletedNot Applicable

Autologous Fat Grafting Versus Subepithelial Connective Tissue Graft for Volume Augmentation

Egypt20 participantsStarted 2018-12-17

Plain-language summary

The aim of this study was to evaluate the effectiveness of autologous fat as a grafting material for soft tissue volume augmentation of localized horizontal ridge defects in humans.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients had at least one localized horizontal ridge defect in a single tooth gap requiring soft tissue volume augmentation.
✓. Teeth in the defect area have been extracted at least 3 months prior to enrolment
✓. All patients were systemically healthy
✓. Patients were non-smokers
✓. Patients had abdominal fat accumulation allowing liposuction
✓. Ability to understand the nature of the proposed surgery and ability to sign an informed consent form

Exclusion criteria

✕. General contra-indications to surgical procedures
✕. Pregnancy
✕. Systemic diseases like Diabetes Mellitus and autoimmune diseases
✕. History of malignancy, chemotherapy or radiotherapy within the last 5 years
✕. Concurrent medication affecting mucosal healing in general (e.g. steroids, large doses of anti-inflammatory drugs)

What they're measuring

Volumetric analysis to evaluate soft tissue volume changes

Timeframe: 1 month

Volumetric analysis to evaluate soft tissue volume changes

Timeframe: 2 months

Volumetric analysis to evaluate soft tissue volume changes

Timeframe: 3 months

Trial details

NCT IDNCT04214041

SponsorNourhan M.Aly

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-06-25

View on ClinicalTrials.gov More Alveolar Bone Loss trials